Hoth Therapeutics Stock Performance

HOTH -  USA Stock  

USD 1.16  0.02  1.69%

The company retains a Market Volatility (i.e., Beta) of 0.3289, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Hoth Therapeutics's beta means in this case. As returns on the market increase, Hoth Therapeutics returns are expected to increase less than the market. However, during the bear market, the loss on holding Hoth Therapeutics will be expected to be smaller as well. Even though it is essential to pay attention to Hoth Therapeutics current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Hoth Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate its performance. Hoth Therapeutics has an expected return of -0.25%. Please be advised to check out Hoth Therapeutics information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Hoth Therapeutics performance from the past will be repeated at some point in the near future.

Hoth Therapeutics Stock Performance 

 
Refresh
 Hoth Therapeutics Performance
0 of 100
Over the last 90 days Hoth Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in November 2021. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Hoth Therapeutics Price Channel

Quick Ratio14.29
Fifty Two Week Low1.1100
Target High Price10.00
Fifty Two Week High3.5000
Target Low Price10.00

Hoth Therapeutics Relative Risk vs. Return Landscape

If you would invest  139.00  in Hoth Therapeutics on July 20, 2021 and sell it today you would lose (23.00)  from holding Hoth Therapeutics or give up 16.55% of portfolio value over 90 days. Hoth Therapeutics is currently does not generate positive expected returns and assumes 2.6977% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Hoth Therapeutics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Hoth Therapeutics is expected to under-perform the market. In addition to that, the company is 3.75 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.05 per unit of volatility.

Hoth Therapeutics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Hoth Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hoth Therapeutics, and traders can use it to determine the average amount a Hoth Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0914

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsHOTH
Estimated Market Risk
 2.7
  actual daily
 
 23 %
of total potential
 
2323
Expected Return
 -0.25
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.09
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Hoth Therapeutics is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hoth Therapeutics by adding it to a well-diversified portfolio.

About Hoth Therapeutics Performance

To evaluate Hoth Therapeutics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Hoth Therapeutics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Hoth Therapeutics Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Hoth Therapeutics stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Hoth Therapeutics's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Effect of Exchange Rate Changes on Cash-13.8 K-14.9 K
Return on Average Assets(1.20) (1.30) 
Return on Average Equity(1.33) (1.43) 
Return on Invested Capital(4.61) (4.73) 
Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Things to note about Hoth Therapeutics

Checking the ongoing alerts about Hoth Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hoth Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Hoth Therapeutics Alerts

Equity Alerts and Improvement Suggestions

Hoth Therapeutics generated a negative expected return over the last 90 days
Hoth Therapeutics may become a speculative penny stock
Hoth Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (10.41 M).
Hoth Therapeutics currently holds about 17.43 M in cash with (7.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Hoth Therapeutics has a frail financial position based on the latest SEC disclosures
Roughly 16.0% of the company shares are held by company insiders
Latest headline from www.equities.com: Hoth gains 0.86 percent for October 13 - Equities.com
Please check Risk vs Return Analysis. Note that the Hoth Therapeutics information on this page should be used as a complementary analysis to other Hoth Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Hoth Therapeutics Stock analysis

When running Hoth Therapeutics price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth Therapeutics that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Hoth Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.